Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11485)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 21, 2019 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rozengurt E, Eibl G. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. World J Gastroenterol 2019; 25(15): 1797-1816 [PMID: 31057295 DOI: 10.3748/wjg.v25.i15.1797] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i15/1797.htm |
| Number | Citing Articles |
| 1 |
Zihuang Li, Hongli Yang, Ling Ye, Rencui Quan, Meili Chen. Role of exosomal miRNAs in brain metastasis affected by radiotherapy. Translational Neuroscience 2021; 12(1): 127 doi: 10.1515/tnsci-2020-0163
|
| 2 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
|
| 3 |
Ling Zhou, Qiaoyun Wang, Han Zhang, Youjie Li, Shuyang Xie, Maolei Xu. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine. Biomolecules 2019; 9(10): 620 doi: 10.3390/biom9100620
|
| 4 |
Matthew Hadden, Anubhav Mittal, Jaswinder Samra, Hala Zreiqat, Sumit Sahni, Yogambha Ramaswamy. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188418 doi: 10.1016/j.bbcan.2020.188418
|
| 5 |
Yaroslav Teper, Guido Eibl. Pancreatic Macrophages: Critical Players in Obesity-Promoted Pancreatic Cancer. Cancers 2020; 12(7): 1946 doi: 10.3390/cancers12071946
|
| 6 |
Nikitha Vobugari, Kai Sun. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. 2023; doi: 10.5772/intechopen.110216
|
| 7 |
Enrique Rozengurt, Guido Eibl. Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance. Cancers 2021; 13(20): 5126 doi: 10.3390/cancers13205126
|
| 8 |
Guido Eibl, Enrique Rozengurt. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer. Cancer and Metastasis Reviews 2021; 40(3): 865 doi: 10.1007/s10555-021-09977-z
|
| 9 |
Qiuping Liu, Xiaomeng Liu, Guanbin Song. The Hippo Pathway: A Master Regulatory Network Important in Cancer. Cells 2021; 10(6): 1416 doi: 10.3390/cells10061416
|
| 10 |
James Sinnett-Smith, Tarique Anwar, Elaine F. Reed, Yaroslav Teper, Guido Eibl, Enrique Rozengurt. Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy. Molecular Cancer Therapeutics 2022; 21(11): 1652 doi: 10.1158/1535-7163.MCT-21-0964
|
| 11 |
Yuvasri Golivi, Seema Kumari, Batoul Farran, Afroz Alam, Sujatha Peela, Ganji Purnachandra Nagaraju. Small molecular inhibitors: Therapeutic strategies for pancreatic cancer. Drug Discovery Today 2024; 29(7): 104053 doi: 10.1016/j.drudis.2024.104053
|
| 12 |
Hui-Hua Chang, Guido Eibl. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma. Cells 2019; 8(7): 673 doi: 10.3390/cells8070673
|
| 13 |
Francesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, Davide Carlo Ambrosetti, Valentina Sancisi. Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188341 doi: 10.1016/j.bbcan.2020.188341
|
| 14 |
Guido Eibl, Enrique Rozengurt. Obesity and Pancreatic Cancer: Insight into Mechanisms. Cancers 2021; 13(20): 5067 doi: 10.3390/cancers13205067
|
| 15 |
Yang-Yang Wang, Liang Li, Xiu-Jun Liu, Qing-Fang Miao, Yi Li, Meng-Ran Zhang, Yong-Su Zhen. Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer. Journal of Pharmaceutical Analysis 2022; 12(2): 232 doi: 10.1016/j.jpha.2021.07.001
|
| 16 |
Yaroslav Teper, Linda Ye, Richard T. Waldron, Aurelia Lugea, Xiaoying Sun, James Sinnett-Smith, Oscar J. Hines, Stephen J. Pandol, Enrique Rozengurt, Guido Eibl. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43498-9
|
| 17 |
Xufeng Tao, Hong Xiang, Yue Pan, Dong Shang, Junchao Guo, Ge Gao, Gary Guishan Xiao. Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence. Pharmacological Research 2021; 168: 105595 doi: 10.1016/j.phrs.2021.105595
|